Novanta (NOVT) announced that its board of directors has authorized the repurchase of up to an additional $200M of the company’s outstanding common shares, adding capacity to the $31M remaining from its 2020 board authorization, for a total capacity of $231M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOVT:
- Novanta price target lowered to $133 from $139 at Baird
- Novanta Inc. Reports Solid Q2 2025 Financial Results Amid Challenging Environment
- Novanta Reports Steady Q2 2025 Financial Performance
- Novanta’s Earnings Call: Mixed Outlook with Strategic Wins
- Novanta reports Q2 adjusted EPS 76c, consensus 73c